Key Laboratory of New Animal Drug of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China
Auto-generated profile, based on publicly available information
Xiao Xu
Key Laboratory of New Animal Drug of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China
Fatty liver hemorrhagic syndrome (FLHS) is a common metabolic disorder in laying hens, leading to reduced egg production and economic losses. Aspirin eugenol ester (AEE) has lipid-lowering, anti-inflammatory, and antioxidant properties, but its effects on FLHS are unknown. This study evaluated the protective effects of AEE using an in vivo FLHS model induced by a high-energy low-protein diet in laying hens and an in vitro steatosis model established by free fatty acid treatment in LMH cells. AEE alleviated liver histopathological damage, reduced oxidative stress (decreased ROS and MDA; increased SOD, GSH, and CAT), and suppressed inflammatory responses. The hepatoprotective effects of AEE were tentatively associated with altered molecular expression of the Nrf2 antioxidant pathway and MAPK/NF-κB inflammatory signaling; however, this correlation was speculated based on molecular detection and incomplete in vitro pharmacological interventions, lacking rigorous causal validation. These findings suggest that AEE alleviates FLHS-related liver injury in laying hens, possibly in association with altered oxidative and inflammatory status. Collectively, these preliminary findings provide a limited theoretical reference for the potential application of AEE as a preventive agent against FLHS in laying hens.
Background: Fatty liver hemorrhagic syndrome (FLHS) is a nutritional-metabolic disorder of laying hens with pathological features analogous to human non-alcoholic fatty liver disease (NAFLD). Aspirin eugenol ester (AEE) has lipid-lowering, anti-inflammatory, and antioxidant activities; however, its protective effects and the underlying molecular mechanisms against FLHS remain unclear. Methods: In this study, we established an in vivo FLHS model in laying hens using a high-energy low-protein diet and an in vitro steatosis model induced by free fatty acids in LMH cells, to explore the hepatoprotective function of AEE. Results: AEE alleviated hepatic lipid accumulation and histopathological lesions, and decreased lipid levels in serum and liver tissue. AEE downregulated the expression of key lipogenic enzymes and upregulated the expression of genes responsible for fatty acid β-oxidation. RNA-seq analysis indicated that the AMPK signaling pathway and autophagy were tightly linked to the hepatoprotective effects of AEE. Treatment with the autophagy activator rapamycin recapitulated the protective effects of AEE, whereas the autophagy inhibitor chloroquine abrogated these beneficial effects. Furthermore, the AMPK inhibitor dorsomorphin partially reversed AEE-mediated liver protection, while the AMPK activator AICAR reproduced the protective effects of AEE. Conclusions: These results indicate that AEE alleviates FLHS in laying hens at least partly through modulation of fatty acid metabolism, likely associated with AMPK/mTOR-mediated autophagy. This work provides mechanistic insights for AEE as a candidate agent for preventing diet-triggered hepatic steatosis.